Thomson Reuters, a distinguished brokerage company, has placed a 52-week price target of $30.50 on Vitamin Shoppe, Inc (NYSE:VSI) shares after it surveyed top market analysts. Calculating estimated earnings after taking into consideration different elements, it is predicted to come at $2.17 for the next fiscal and $N/A for underway quarter.
Analysts take into account the price to earnings ratio to estimate the firm’s valuation. This ratio, which is also called as the P/E ratio evaluates the company on relative expense factor. The formula to calculate ratio is stock’s latest price/ per share earnings. The P/E ratio of Vitamin Shoppe, Inc (NYSE:VSI) stands at 16.32.
Analysts also work out Price/Earnings Growth ratio in an attempt to estimate the valuation of a firm. This ratio commonly known as the PEG ratio implies the stock’s valuation compared to earnings growth potential. Investors look to invest in the stocks with a lower PEG ratio. For Vitamin Shoppe, Inc Common Stoc, the PEG ratio for coming 3-5 years is 2.15.
The technical analysis highlights that Vitamin Shoppe, Inc Common Stoc current is trading $-0.67 points away or -2.35% from its 50-day moving average of $28.52. Further it is trading $-1.67 or -5.67% away its 200-day moving average of $29.52.
The 52-week high of Vitamin Shoppe, Inc (NYSE:VSI) was $36.14 while lowest point recorded in 52-week was $26.02. It implies if stock price makes a movement of over $-8.29, it will record a new 52-week high. In the case of +7.03% drop, it will touch a new 52-week low.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...